SE385008B - Sett att framstella cykliskt n-substituerade derivat av 1,4- bensendisulfonamidderivat - Google Patents

Sett att framstella cykliskt n-substituerade derivat av 1,4- bensendisulfonamidderivat

Info

Publication number
SE385008B
SE385008B SE7310996A SE7310996A SE385008B SE 385008 B SE385008 B SE 385008B SE 7310996 A SE7310996 A SE 7310996A SE 7310996 A SE7310996 A SE 7310996A SE 385008 B SE385008 B SE 385008B
Authority
SE
Sweden
Prior art keywords
derivatives
benzenenisulphonamide
preparing cyclic
substituted
substituted derivatives
Prior art date
Application number
SE7310996A
Other languages
English (en)
Swedish (sv)
Inventor
P E Cross
B Gadsby
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE385008B publication Critical patent/SE385008B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B31/00—Disazo and polyazo dyes of the type A->B->C, A->B->C->D, or the like, prepared by diazotising and coupling
    • C09B31/02—Disazo dyes
    • C09B31/12—Disazo dyes from other coupling components "C"
    • C09B31/14—Heterocyclic components

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7310996A 1972-08-12 1973-08-10 Sett att framstella cykliskt n-substituerade derivat av 1,4- bensendisulfonamidderivat SE385008B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3772072A GB1380009A (en) 1972-08-12 1972-08-12 Cyclic derivatives of 1,4-benzene disulphonamide

Publications (1)

Publication Number Publication Date
SE385008B true SE385008B (sv) 1976-05-31

Family

ID=10398552

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7310996A SE385008B (sv) 1972-08-12 1973-08-10 Sett att framstella cykliskt n-substituerade derivat av 1,4- bensendisulfonamidderivat

Country Status (16)

Country Link
US (1) US3867390A (xx)
JP (2) JPS59508B2 (xx)
AT (1) AT331248B (xx)
AU (1) AU5908473A (xx)
BE (1) BE803373A (xx)
CA (1) CA978945A (xx)
DE (1) DE2340010A1 (xx)
ES (1) ES417806A1 (xx)
FR (1) FR2195449B1 (xx)
GB (1) GB1380009A (xx)
IE (1) IE38177B1 (xx)
IN (1) IN139006B (xx)
LU (1) LU68211A1 (xx)
NL (1) NL162641C (xx)
SE (1) SE385008B (xx)
ZA (1) ZA735474B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070361A (en) * 1977-04-21 1978-01-24 E. R. Squibb & Sons, Inc. Mercaptoalkylsulfonyl proline and pipecolic acid and esters thereof
DE2720654A1 (de) * 1977-05-07 1978-11-16 Bayer Ag Azolyl-alkancarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
GB1572226A (en) * 1977-11-03 1980-07-30 Hoechst Uk Ltd Pharmaceutical preparations in solid unit dosage form
JPS5922023A (ja) * 1982-07-27 1984-02-04 Hoya Corp ビ−ムスプリツタ−

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3165550A (en) * 1960-06-29 1965-01-12 Pfizer & Co C N-substituted p-benzenedisulfonamides

Also Published As

Publication number Publication date
GB1380009A (en) 1975-01-08
NL162641B (nl) 1980-01-15
BE803373A (fr) 1974-02-08
ZA735474B (en) 1974-08-28
IE38177B1 (en) 1978-01-18
CA978945A (en) 1975-12-02
JPS59508B2 (ja) 1984-01-07
JPS5857431B2 (ja) 1983-12-20
FR2195449B1 (xx) 1977-09-09
AU5908473A (en) 1975-02-13
LU68211A1 (xx) 1975-05-21
JPS57131774A (en) 1982-08-14
NL162641C (nl) 1980-06-16
IN139006B (xx) 1976-04-24
DE2340010A1 (de) 1974-03-14
FR2195449A1 (xx) 1974-03-08
US3867390A (en) 1975-02-18
JPS4985066A (xx) 1974-08-15
NL7311000A (xx) 1974-02-14
ATA691573A (de) 1975-11-15
ES417806A1 (es) 1976-03-01
IE38177L (en) 1974-02-12
AT331248B (de) 1976-08-10

Similar Documents

Publication Publication Date Title
SE390022B (sv) Sett for framstellning av n-(1,1,1-trisubstituerade)-metylazoler
SE401675B (sv) Sett att framstella 1,3-oxazolo/4,5-b/pyridinderivat
SE402103B (sv) Sett att framstella vissa angivna 1-(4-fenoxi-fenyl)-1,3,5-triazinderivat
SE398880B (sv) Sett att framstella basiskt substituerade 3-bensoyl-bensofuranderivat
SE403478B (sv) Sett att framstella 2,2,6,6-tetrametyl-4-oxopiperidin
SE386173B (sv) Sett att framstella 2-oxazolinderivat.
SE406327B (sv) Sett att framstella d-homo-1,4-pregnadien-3,20-dioner
SE388420B (sv) Sett att framstella cyklopropylmetylaminderivat
SE385707B (sv) Sett att framstella 8,9-didehydro-10-alkoxi-ergolenderivat
SE385008B (sv) Sett att framstella cykliskt n-substituerade derivat av 1,4- bensendisulfonamidderivat
SE397190B (sv) Sett att framstella substituerade dibensocykloheptener
SE425248B (sv) Forfarande for framstellning ac derivat av 4-tia-2,6-diaza(3.2.0)-2-hepten-oner
SE410190B (sv) Sett att framstella aminopyrazolo(5,1-a)isokinolinderivat
SE415475B (sv) Forfarande for framstellning av 4,5-didehydro-pgf?711alfa
SE387119B (sv) Sett att framstella derivat av 6-gamma-dialkylaminoalkoxi-4,7-dimetoxibensofuraner
SE7508858L (sv) Sett att framstella basiska derivat av 1-aryl-2-oxo-2,4,5,7,7a-hexahydroindoler.
SE404192B (sv) Sett att framstella 3 beta-cykloalkyloxi-16 alfa-cyanopregn-5-en-20-oner
SE399711B (sv) Sett att framstella ett derivat av 6 alfa-metylprednisolon
SE394890B (sv) Sett att framstella derivat av 4'-aminometyl-dibenso (b,e) -spiro (11-oxepin-2'-dioxolan-1', 3')
SE394818B (sv) Sett att framstella dihydrokumarin och alkylerade derivat derav
SE398644B (sv) Sett att framstella farmaceutiskt aktiva 2,10-diklor-12-metyl-(2h-dibenso(d g))1,3)-dioxocinderivat
SE380801B (sv) Sett att framstella pyronoderivat av rifamyciner
SE385302B (sv) Sett att framstella 5-aminometyl-6-karbetoxi-oxazino(5',6'e)indolderivat
SE396751B (sv) Sett att framstella s?72iv-benso-1,2,4-tiadiaziner
SE399889B (sv) Sett att framstella 1,4-bensodioxanderivat